EL-A: Writing original draft
Retatrutide does not significantly stimulate growth hormone production
Ryan said that "we do need better evidence" around whether some individuals can maintain weight loss after coming off GLP-1s, but she thinks what "Calibrate is doing is sharing the decision-making with the patient and trying to adapt to the environment where drugs may not always be available." Since Calibrate has come onto the market, results were published from a much larger, peer-reviewed study funded by the Ozempic manufacturer Novo Nordisk in 2022
In addition, GLP-1R agonists help treat diabetes by protecting the brain and heart, preserving kidney function and aiding weight loss (Abiola et al., 2024)
Originally, patients had to take extenatide twice a day
Typically, people with a personal or family history of certain types of thyroid cancer, those with a history of pancreatitis or gastroparesis, and those who are pregnant or planning to be should not take these medications